Human medicines European public assessment report (EPAR): Seebri Breezhaler, glycopyrronium bromide, Revision: 8, Authorised

05:31 EDT 18 Jul 2018 | European Medicines Agency

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Seebri Breezhaler, glycopyrronium bromide, Revision: 8, Authorised"